Relationship between lithium carbonate and the risk of Parkinson-like events in patients with bipolar disorders: A multivariate analysis using the Japanese adverse drug event report database

[1]  J. Morgan,et al.  Drug-induced tremor, clinical features, diagnostic approach and management , 2022, Journal of the Neurological Sciences.

[2]  Y. Uwai,et al.  Surveillance of drug overdose and identification of its risk factors by a multivariate analysis using the Japanese Adverse Drug Event Report database. , 2021, Asian journal of psychiatry.

[3]  M. Okuda,et al.  Concomitant febuxostat enhances methotrexate-induced hepatotoxicity by inhibiting breast cancer resistance protein , 2019, Scientific Reports.

[4]  L. Citrome,et al.  Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia—Key Differences in Pathophysiology and Clinical Management , 2018, Neurology and Therapy.

[5]  D. Torres-Russotto,et al.  The clinical features and functional impact of valproate-induced tremor. , 2017, Parkinsonism & related disorders.

[6]  M. Gitlin.  Lithium side effects and toxicity: prevalence and management strategies , 2016, International Journal of Bipolar Disorders.

[7]  T. Outhred,et al.  Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding , 2016, CNS Drugs.

[8]  K. Bhatia,et al.  Valproate-Associated Parkinsonism: A Critical Review of the Literature , 2016, CNS Drugs.

[9]  T. Nakagawa,et al.  Prevention of antipsychotic-induced hyperglycaemia by vitamin D: a data mining prediction followed by experimental exploration of the molecular mechanism , 2016, Scientific Reports.

[10]  B. Mulsant,et al.  Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial , 2015, The Lancet.

[11]  S. Chung,et al.  Drug-Induced Parkinsonism , 2012, Journal of clinical neurology.

[12]  Yizheng Wang,et al.  Inhibition of glycogen synthase kinase-3β protects dopaminergic neurons from MPTP toxicity , 2007, Neuropharmacology.

[13]  Xiaohua Li,et al.  Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium , 2002, Neuropharmacology.

[14]  G. Golüke-Willemse,et al.  Extrapyramidal Syndrome due to Valproate Adminstration as an Adjunct to Lithium in an Elderly Manic Patient , 1997, International journal of geriatric psychiatry.

[15]  P. Vestergaard,et al.  Prospective studies on a lithium cohort , 1988, Acta psychiatrica Scandinavica.